In a webinar sponsored by fintech business Mercury, investors from Breyer Capital and MBX Capital shared their startup trend perspectives on AI, valuation, and alternative funding.
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.
Sheila Bond, MD, talked about the latest trends regarding integration of AI in healthcare.
Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick.